Alice P. L.
- Country
- France
- Department
- Seine-Maritime
Research Overview
Data & Insights
Has run more than one trial at 0 of 12 partner sites.
Specializations
Oncology – Solid Tumors
The investigator’s work encompasses a broad spectrum of malignant neoplasms, emphasizing therapeutic strategies for advanced disease stages.
- Non‑small cell lung cancer
- melanoma
- colorectal carcinoma
- hepatocellular carcinoma
- pancreatic adenocarcinoma
Focuses on targeted agents and immunotherapy across metastatic settings.
Autoimmune and Inflammatory Disorders
Research addresses immune‑mediated conditions, aiming to modulate pathogenic pathways.
- ANCA‑associated vasculitis
- systemic lupus erythematosus
- rheumatoid arthritis
- psoriatic arthritis
- hidradenitis suppurativa
Emphasizes biologic and small‑molecule interventions.
Cardiovascular and Metabolic Medicine
Investigations target diseases of the heart, vessels, and metabolic regulation.
- acute coronary syndrome
- atrial fibrillation
- heart failure with reduced ejection fraction
- chronic kidney disease
- type‑2 diabetes mellitus
Integrates cardiovascular risk reduction with renal and glycemic outcomes.
Neurology and Neurodegeneration
Focuses on central nervous system disorders, ranging from acute vascular events to progressive dementias.
- ischemic stroke
- Alzheimer’s disease
- multiple sclerosis
- Parkinson’s disease
- diffuse intrinsic pontine glioma
Explores neuroprotective and disease‑modifying therapeutic approaches.
Infectious and Pulmonary Conditions
Encompasses respiratory infections, chronic lung diseases, and systemic infectious challenges.
- chronic obstructive pulmonary disease
- chronic pulmonary aspergillosis
- severe influenza infection
- HIV‑1 infection
- cystic fibrosis
Targets antimicrobial strategies and host immune modulation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.